Announced Wed, 24 Jun · 11:22 IST
Trading window closed ahead of Q1 FY27 results
Compliance View source PDF
BALPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.2%1-day move
₹85.40
prior close
₹84.30
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.2-3.2-7.3-8.4-6.2-7.4-10.8+1.9+2.3——
Up moveDown movePending
AI summary
Bal Pharma has closed its trading window from 1 July 2026 until 48 hours after declaring unaudited financial results for the quarter ended 30 June 2026. This is a routine compliance measure under SEBI insider trading regulations. Designated persons and their immediate relatives cannot trade in company shares during this period. The board meeting date for results will be announced in due course.
Likely market impact
Routine regulatory filing with no direct impact on shareholders. Signals that Q1 FY27 results are approaching.